Global Inactivated Influenza Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Inactivated Influenza Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Inactivated Influenza Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Inactivated Influenza Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Inactivated Influenza Vaccine Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Inactivated Influenza Vaccine Sales by Type

2.3.1 Global Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Inactivated Influenza Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Inactivated Influenza Vaccine Sale Price by Type (2017-2022)

2.4 Inactivated Influenza Vaccine Segment by Application

2.4.1 Children

2.4.2 Adolescence

2.4.3 Adults

2.4.4 Elderly

2.5 Inactivated Influenza Vaccine Sales by Application

2.5.1 Global Inactivated Influenza Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Inactivated Influenza Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Inactivated Influenza Vaccine Sale Price by Application (2017-2022)

3 Global Inactivated Influenza Vaccine by Company

3.1 Global Inactivated Influenza Vaccine Breakdown Data by Company

3.1.1 Global Inactivated Influenza Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Inactivated Influenza Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Inactivated Influenza Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Inactivated Influenza Vaccine Revenue by Company (2020-2022)

3.2.2 Global Inactivated Influenza Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Inactivated Influenza Vaccine Sale Price by Company

3.4 Key Manufacturers Inactivated Influenza Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Inactivated Influenza Vaccine Product Location Distribution

3.4.2 Players Inactivated Influenza Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Inactivated Influenza Vaccine by Geographic Region

4.1 World Historic Inactivated Influenza Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Inactivated Influenza Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Inactivated Influenza Vaccine Annual Revenue by Geographic Region

4.2 World Historic Inactivated Influenza Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Inactivated Influenza Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Inactivated Influenza Vaccine Annual Revenue by Country/Region

4.3 Americas Inactivated Influenza Vaccine Sales Growth

4.4 APAC Inactivated Influenza Vaccine Sales Growth

4.5 Europe Inactivated Influenza Vaccine Sales Growth

4.6 Middle East & Africa Inactivated Influenza Vaccine Sales Growth

5 Americas

5.1 Americas Inactivated Influenza Vaccine Sales by Country

5.1.1 Americas Inactivated Influenza Vaccine Sales by Country (2017-2022)

5.1.2 Americas Inactivated Influenza Vaccine Revenue by Country (2017-2022)

5.2 Americas Inactivated Influenza Vaccine Sales by Type

5.3 Americas Inactivated Influenza Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Inactivated Influenza Vaccine Sales by Region

6.1.1 APAC Inactivated Influenza Vaccine Sales by Region (2017-2022)

6.1.2 APAC Inactivated Influenza Vaccine Revenue by Region (2017-2022)

6.2 APAC Inactivated Influenza Vaccine Sales by Type

6.3 APAC Inactivated Influenza Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Inactivated Influenza Vaccine by Country

7.1.1 Europe Inactivated Influenza Vaccine Sales by Country (2017-2022)

7.1.2 Europe Inactivated Influenza Vaccine Revenue by Country (2017-2022)

7.2 Europe Inactivated Influenza Vaccine Sales by Type

7.3 Europe Inactivated Influenza Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Inactivated Influenza Vaccine by Country

8.1.1 Middle East & Africa Inactivated Influenza Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Inactivated Influenza Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Inactivated Influenza Vaccine Sales by Type

8.3 Middle East & Africa Inactivated Influenza Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Inactivated Influenza Vaccine

10.3 Manufacturing Process Analysis of Inactivated Influenza Vaccine

10.4 Industry Chain Structure of Inactivated Influenza Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Inactivated Influenza Vaccine Distributors

11.3 Inactivated Influenza Vaccine Customer

12 World Forecast Review for Inactivated Influenza Vaccine by Geographic Region

12.1 Global Inactivated Influenza Vaccine Market Size Forecast by Region

12.1.1 Global Inactivated Influenza Vaccine Forecast by Region (2023-2028)

12.1.2 Global Inactivated Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Inactivated Influenza Vaccine Forecast by Type

12.7 Global Inactivated Influenza Vaccine Forecast by Application

13 Key Players Analysis

13.1 CSL Limited

13.1.1 CSL Limited Company Information

13.1.2 CSL Limited Inactivated Influenza Vaccine Product Offered

13.1.3 CSL Limited Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CSL Limited Main Business Overview

13.1.5 CSL Limited Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Inactivated Influenza Vaccine Product Offered

13.2.3 GSK Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Sanofi Pasteur

13.3.1 Sanofi Pasteur Company Information

13.3.2 Sanofi Pasteur Inactivated Influenza Vaccine Product Offered

13.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Pasteur Main Business Overview

13.3.5 Sanofi Pasteur Latest Developments

13.4 Viatris

13.4.1 Viatris Company Information

13.4.2 Viatris Inactivated Influenza Vaccine Product Offered

13.4.3 Viatris Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Viatris Main Business Overview

13.4.5 Viatris Latest Developments

13.5 Hualan Biological

13.5.1 Hualan Biological Company Information

13.5.2 Hualan Biological Inactivated Influenza Vaccine Product Offered

13.5.3 Hualan Biological Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hualan Biological Main Business Overview

13.5.5 Hualan Biological Latest Developments

13.6 AstraZeneca

13.6.1 AstraZeneca Company Information

13.6.2 AstraZeneca Inactivated Influenza Vaccine Product Offered

13.6.3 AstraZeneca Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AstraZeneca Main Business Overview

13.6.5 AstraZeneca Latest Developments

13.7 Sinovac Biotech

13.7.1 Sinovac Biotech Company Information

13.7.2 Sinovac Biotech Inactivated Influenza Vaccine Product Offered

13.7.3 Sinovac Biotech Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sinovac Biotech Main Business Overview

13.7.5 Sinovac Biotech Latest Developments

13.8 Aleph Biomedical

13.8.1 Aleph Biomedical Company Information

13.8.2 Aleph Biomedical Inactivated Influenza Vaccine Product Offered

13.8.3 Aleph Biomedical Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Aleph Biomedical Main Business Overview

13.8.5 Aleph Biomedical Latest Developments

13.9 Abbott Laboratories

13.9.1 Abbott Laboratories Company Information

13.9.2 Abbott Laboratories Inactivated Influenza Vaccine Product Offered

13.9.3 Abbott Laboratories Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Abbott Laboratories Main Business Overview

13.9.5 Abbott Laboratories Latest Developments

13.10 Novartis International

13.10.1 Novartis International Company Information

13.10.2 Novartis International Inactivated Influenza Vaccine Product Offered

13.10.3 Novartis International Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis International Main Business Overview

13.10.5 Novartis International Latest Developments

14 Research Findings and Conclusion

Table 1. Inactivated Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Inactivated Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Trivalent Influenza Vaccine

Table 4. Major Players of Quadrivalent Influenza Vaccine

Table 5. Global Inactivated Influenza Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Inactivated Influenza Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Inactivated Influenza Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Inactivated Influenza Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Inactivated Influenza Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Inactivated Influenza Vaccine Revenue by Application (2017-2022)

Table 13. Global Inactivated Influenza Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Inactivated Influenza Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Inactivated Influenza Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Inactivated Influenza Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Inactivated Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Inactivated Influenza Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Inactivated Influenza Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Inactivated Influenza Vaccine Producing Area Distribution and Sales Area

Table 21. Players Inactivated Influenza Vaccine Products Offered

Table 22. Inactivated Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Inactivated Influenza Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Inactivated Influenza Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Inactivated Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Inactivated Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Inactivated Influenza Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Inactivated Influenza Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Inactivated Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Inactivated Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Inactivated Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Inactivated Influenza Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Inactivated Influenza Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Inactivated Influenza Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Inactivated Influenza Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Inactivated Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Inactivated Influenza Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Inactivated Influenza Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Inactivated Influenza Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Inactivated Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Inactivated Influenza Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Inactivated Influenza Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Inactivated Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Inactivated Influenza Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Inactivated Influenza Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Inactivated Influenza Vaccine

Table 66. Key Market Challenges & Risks of Inactivated Influenza Vaccine

Table 67. Key Industry Trends of Inactivated Influenza Vaccine

Table 68. Inactivated Influenza Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Inactivated Influenza Vaccine Distributors List

Table 71. Inactivated Influenza Vaccine Customer List

Table 72. Global Inactivated Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Inactivated Influenza Vaccine Sales Market Forecast by Region

Table 74. Global Inactivated Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Inactivated Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Inactivated Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Inactivated Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Inactivated Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Inactivated Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Inactivated Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Inactivated Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Inactivated Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Inactivated Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Inactivated Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Inactivated Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Inactivated Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Inactivated Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Inactivated Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Inactivated Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. CSL Limited Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. CSL Limited Inactivated Influenza Vaccine Product Offered

Table 94. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. CSL Limited Main Business

Table 96. CSL Limited Latest Developments

Table 97. GSK Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Inactivated Influenza Vaccine Product Offered

Table 99. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Sanofi Pasteur Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Pasteur Inactivated Influenza Vaccine Product Offered

Table 104. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Pasteur Main Business

Table 106. Sanofi Pasteur Latest Developments

Table 107. Viatris Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Viatris Inactivated Influenza Vaccine Product Offered

Table 109. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Viatris Main Business

Table 111. Viatris Latest Developments

Table 112. Hualan Biological Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Hualan Biological Inactivated Influenza Vaccine Product Offered

Table 114. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Hualan Biological Main Business

Table 116. Hualan Biological Latest Developments

Table 117. AstraZeneca Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. AstraZeneca Inactivated Influenza Vaccine Product Offered

Table 119. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. AstraZeneca Main Business

Table 121. AstraZeneca Latest Developments

Table 122. Sinovac Biotech Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Sinovac Biotech Inactivated Influenza Vaccine Product Offered

Table 124. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Sinovac Biotech Main Business

Table 126. Sinovac Biotech Latest Developments

Table 127. Aleph Biomedical Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Aleph Biomedical Inactivated Influenza Vaccine Product Offered

Table 129. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Aleph Biomedical Main Business

Table 131. Aleph Biomedical Latest Developments

Table 132. Abbott Laboratories Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Abbott Laboratories Inactivated Influenza Vaccine Product Offered

Table 134. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Abbott Laboratories Main Business

Table 136. Abbott Laboratories Latest Developments

Table 137. Novartis International Basic Information, Inactivated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Novartis International Inactivated Influenza Vaccine Product Offered

Table 139. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Novartis International Main Business

Table 141. Novartis International Latest Developments

List of Figures

Figure 1. Picture of Inactivated Influenza Vaccine

Figure 2. Inactivated Influenza Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Inactivated Influenza Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Inactivated Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Inactivated Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Inactivated Influenza Vaccine Sales Market Share by Type in 2021

Figure 12. Global Inactivated Influenza Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Inactivated Influenza Vaccine Consumed in Children

Figure 14. Global Inactivated Influenza Vaccine Market: Children (2017-2022) & (K Units)

Figure 15. Inactivated Influenza Vaccine Consumed in Adolescence

Figure 16. Global Inactivated Influenza Vaccine Market: Adolescence (2017-2022) & (K Units)

Figure 17. Inactivated Influenza Vaccine Consumed in Adults

Figure 18. Global Inactivated Influenza Vaccine Market: Adults (2017-2022) & (K Units)

Figure 19. Inactivated Influenza Vaccine Consumed in Elderly

Figure 20. Global Inactivated Influenza Vaccine Market: Elderly (2017-2022) & (K Units)

Figure 21. Global Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Figure 22. Global Inactivated Influenza Vaccine Revenue Market Share by Application in 2021

Figure 23. Inactivated Influenza Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Inactivated Influenza Vaccine Revenue Market Share by Company in 2021

Figure 25. Global Inactivated Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Inactivated Influenza Vaccine Revenue Market Share by Geographic Region in 2021

Figure 27. Global Inactivated Influenza Vaccine Sales Market Share by Region (2017-2022)

Figure 28. Global Inactivated Influenza Vaccine Revenue Market Share by Country/Region in 2021

Figure 29. Americas Inactivated Influenza Vaccine Sales 2017-2022 (K Units)

Figure 30. Americas Inactivated Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. APAC Inactivated Influenza Vaccine Sales 2017-2022 (K Units)

Figure 32. APAC Inactivated Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Europe Inactivated Influenza Vaccine Sales 2017-2022 (K Units)

Figure 34. Europe Inactivated Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Inactivated Influenza Vaccine Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Inactivated Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Americas Inactivated Influenza Vaccine Sales Market Share by Country in 2021

Figure 38. Americas Inactivated Influenza Vaccine Revenue Market Share by Country in 2021

Figure 39. United States Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Inactivated Influenza Vaccine Sales Market Share by Region in 2021

Figure 44. APAC Inactivated Influenza Vaccine Revenue Market Share by Regions in 2021

Figure 45. China Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Inactivated Influenza Vaccine Sales Market Share by Country in 2021

Figure 52. Europe Inactivated Influenza Vaccine Revenue Market Share by Country in 2021

Figure 53. Germany Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Inactivated Influenza Vaccine Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Inactivated Influenza Vaccine Revenue Market Share by Country in 2021

Figure 60. Egypt Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Inactivated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Inactivated Influenza Vaccine in 2021

Figure 66. Manufacturing Process Analysis of Inactivated Influenza Vaccine

Figure 67. Industry Chain Structure of Inactivated Influenza Vaccine

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles